Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir
Submissions based on favorable MagnetisMM-3 trial results in patients with relapsed or refractory multiple myeloma
The company is pleased to report positive performances from all divisions this quarter. Growth in our research divisions, Discovery Services and the Dedicated Centres was solid
India is working towards augmenting health infrastructure and have initiated multiple schemes to strengthen health systems and improve health service delivery
The hospital will have all the modern facilities like modular OT, state of the art medical equipment, labs, etc. It will have OPD and IPD services
Dr. Mandaviya and Dharmendra Pradhan dedicate Burns Centre at AIIMS; Lays foundation stone of Critical Care Hospital Building, and award 40 gold medals to meritorious students
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
The product is expected to be launched by Q4 FY23.
Subscribe To Our Newsletter & Stay Updated
